AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19515630 — intervention group
Group type: COMPARATOR
Intervention: Ritodrine
Number of subjects: 45
Study 17668562 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate treatment switch
Number of subjects: 47
Study 17668562 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment switch
Number of subjects: 47
Study 17668562 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 47
Study 15112118 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal hand dystonia (FHD) subjects
Number of subjects: 20
Study 15112118 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 20
Study 11125195 — intervention group
Group type: EXPERIMENTAL
Intervention: 5,000 ppm fluoride dentifrice (Prevident 5000 Plus)
Number of subjects: 201
Study 11125195 — intervention group
Group type: COMPARATOR
Intervention: 1,100 ppm fluoride dentifrice (Winterfresh Gel)
Number of subjects: 201
Study 9586886 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa 8 million U subcutaneously daily
Number of subjects: 108
Study 9586886 — intervention group
Group type: COMPARATOR
Intervention: Interferon alfa 1 million U subcutaneously daily
Number of subjects: 108
Study 7774334 — intervention group
Group type: EXPERIMENTAL
Intervention: Flow Triggering (FT) with the 7200ae ventilator
Number of subjects: 10
Study 7774334 — intervention group
Group type: COMPARATOR
Intervention: Pressure Triggering (PT) with the 7200ae ventilator
Number of subjects: 10
Study 7774334 — intervention group
Group type: EXPERIMENTAL
Intervention: Flow Triggering (FT) with the Veolar ventilator
Number of subjects: 10
Study 7774334 — intervention group
Group type: COMPARATOR
Intervention: Pressure Triggering (PT) with the Veolar ventilator
Number of subjects: 10
Study 3132930 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lipid infusion alone
Number of subjects: 15
Study 3132930 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid with amino acids
Number of subjects: 15
Study 3132930 — intervention group
Group type: COMPARATOR
Intervention: Amino acids alone
Number of subjects: 15
Study 28634748 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab 8 mg/kg in combination with 80 mg/m2 paclitaxel
Number of subjects: 222
Study 28634748 — intervention group
Group type: COMPARATOR
Intervention: Placebo in combination with 80 mg/m2 paclitaxel
Number of subjects: 222
Study 27056606 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 100
Study 27056606 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 24055281 — intervention group
Group type: EXPERIMENTAL
Intervention: Transgastric echocardiography
Number of subjects: 21
Study 22901843 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie diet with carbohydrates eaten at dinner
Number of subjects: 78
Study 22901843 — intervention group
Group type: COMPARATOR
Intervention: Standard low-calorie diet
Number of subjects: 78
Study 21122391 — intervention group
Group type: EXPERIMENTAL
Intervention: Interleukin-11 (50 µg × kg(‐1) × d(‐1))
Number of subjects: 70
Study 21122391 — intervention group
Group type: COMPARATOR
Intervention: Control group (no interleukin-11)
Number of subjects: 70
Study 17451667 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial model (MOMIT) for tracking multiple moving objects
Number of subjects: 0
Study 17451667 — intervention group
Group type: EXPERIMENTAL
Intervention: Mathematical version of MOMIT
Number of subjects: 0
Study 16710029 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet intervention
Number of subjects: 741
Study 16710029 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 741
Study 12820332 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant autologous tumor cell lysate vaccine
Number of subjects: 236
Study 11242724 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral trioxide aggregate (MTA)
Number of subjects: 26
Study 11242724 — intervention group
Group type: COMPARATOR
Intervention: Formocresol (FC)
Number of subjects: 26
Study 9211627 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine (5mg daily for 4 weeks)
Number of subjects: 40
Study 7970862 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 0
Study 7970862 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2823859 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g of fish oil daily (1.8 g eicosapentaenoic acid)
Number of subjects: 0
Study 2823859 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplement containing olive oil (iso-energetic)
Number of subjects: 0
Study 29422450 — intervention group
Group type: EXPERIMENTAL
Intervention: Emphasizing the incentive in the subject line of the invitation email
Number of subjects: 2000
Study 29422450 — intervention group
Group type: EXPERIMENTAL
Intervention: Sending the invitation email on Tuesday
Number of subjects: 2000
Study 29422450 — intervention group
Group type: COMPARATOR
Intervention: Sending the invitation email on Friday
Number of subjects: 2000
Study 27589695 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual assistance-based lifestyle intervention (mobile phone messages: 3 per week, e-mails: 2 per week for 1 year)
Number of subjects: 265
Study 27589695 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional intervention)
Number of subjects: 265
Study 27589695 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual assistance-based lifestyle intervention
Number of subjects: 265
Study 26591623 — intervention group
Group type: EXPERIMENTAL
Intervention: Test regimen (TR) including triclosan, PVM/MA copolymer, 0.243% sodium fluoride toothpaste, alcohol-free, fluoride-free CPC mouthwash, and manual toothbrush with cheek and tongue cleaner
Number of subjects: 120
Study 26591623 — intervention group
Group type: EXPERIMENTAL
Intervention: Test regimen (TR)
Number of subjects: 120
Study 26591623 — intervention group
Group type: COMPARATOR
Intervention: Negative control regimen (NCR) including 0.76% sodium monofluorophosphate toothpaste, fluoride-free and alcohol-free non-antibacterial mouthwash, and manual toothbrush with rounded/polished bristles
Number of subjects: 120
Study 24160223 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week aerobic training program, 3 sessions/week, moderate intensity (60-75% HRmax) for 25-40 minutes
Number of subjects: 135
Study 24160223 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 135
Study 20621361 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS (10Hz, 90% of resting MT, 20 trains, 6s duration, 1200 pulses/day)
Number of subjects: 45
Study 20621361 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 45
Study 18978635 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Aftercare (AA) conditions (5-session in-person or brief telephone)
Number of subjects: 177
Study 18978635 — intervention group
Group type: COMPARATOR
Intervention: No Active Aftercare (NA)
Number of subjects: 177
Study 16798303 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral citrulline (1.9 g/m2 per dose, 5 perioperative doses)
Number of subjects: 40
Study 12930586 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 3 embryo transfer
Number of subjects: 118
Study 12930586 — intervention group
Group type: COMPARATOR
Intervention: Day 5 embryo transfer
Number of subjects: 118
Study 11193299 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin + Chlormadinone Acetate (CMA)
Number of subjects: 33
Study 11193299 — intervention group
Group type: COMPARATOR
Intervention: Tamsulosin
Number of subjects: 33
Study 11193299 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin + CMA
Number of subjects: 33
Study 9174878 — intervention group
Group type: COMPARATOR
Intervention: Oral diazepam 0.2 mg/kg
Number of subjects: 50
Study 9174878 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral clonidine 3 micrograms/kg
Number of subjects: 50
Study 30058461 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral-horizontal plyometric training (UH)
Number of subjects: 20
Study 30058461 — intervention group
Group type: COMPARATOR
Intervention: Bilateral-vertical plyometric training (BV)
Number of subjects: 20
Study 29482597 — intervention group
Group type: EXPERIMENTAL
Intervention: General Psychiatric Management (GPM) treatment for BPD
Number of subjects: 99
Study 27562743 — intervention group
Group type: EXPERIMENTAL
Intervention: Short cycle therapy (5 days on, 2 days off ART)
Number of subjects: 199
Study 27562743 — intervention group
Group type: COMPARATOR
Intervention: Continuous therapy (continuous ART)
Number of subjects: 199
Study 27562743 — intervention group
Group type: EXPERIMENTAL
Intervention: Short cycle therapy
Number of subjects: 199
Study 27562743 — intervention group
Group type: COMPARATOR
Intervention: Continuous therapy
Number of subjects: 199
Study 23736923 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulinastatin (100,000 units/10 kg) infused 15 min before blood transfusion or after liver resection
Number of subjects: 44
Study 23736923 — intervention group
Group type: COMPARATOR
Intervention: Blood transfusion
Number of subjects: 44
Study 23736923 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulinastatin
Number of subjects: 44
Study 23736923 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood transfusion and Ulinastatin (BT+UTI group)
Number of subjects: 44
Study 22767410 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdiagnostic cognitive-behavioral group treatment (12 weeks)
Number of subjects: 46
Study 22767410 — intervention group
Group type: COMPARATOR
Intervention: Diagnosis-specific group Cognitive-Behavioral Therapy (CBT) protocols (12 weeks)
Number of subjects: 46
Study 18557812 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg once daily
Number of subjects: 234
Study 16448471 — intervention group
Group type: EXPERIMENTAL
Intervention: Dining room group (supervised dining room)
Number of subjects: 48
Study 16448471 — intervention group
Group type: COMPARATOR
Intervention: Control group (bedside eating)
Number of subjects: 48
Study 16448471 — intervention group
Group type: EXPERIMENTAL
Intervention: Dining room group
Number of subjects: 48
Study 12716796 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 0
Study 12716796 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12035205 — intervention group
Group type: EXPERIMENTAL
Intervention: Efficacy-enhancing experimental group (n = 10)
Number of subjects: 18
Study 12035205 — intervention group
Group type: COMPARATOR
Intervention: Usual-care control group (n = 8)
Number of subjects: 18
Study 9426079 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled phosphoramidon (10[-5] M)
Number of subjects: 12
Study 9426079 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 7506155 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulide (200 mg/day)
Number of subjects: 0
Study 7506155 — intervention group
Group type: COMPARATOR
Intervention: Bromeline (240 mg/day)
Number of subjects: 0
Study 7506155 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3541620 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine electronic fetal monitoring
Number of subjects: 7
Study 3541620 — intervention group
Group type: COMPARATOR
Intervention: Fetal heart rate monitoring by auscultation
Number of subjects: 7
Study 30930132 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (20 mg/kg body weight)
Number of subjects: 20
Study 30930132 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined supplementation with nitrate (7 mg/kg body weight) and vitamin C
Number of subjects: 20
Study 30930132 — intervention group
Group type: COMPARATOR
Intervention: Nitrate (7 mg/kg body weight)
Number of subjects: 20
Study 29863549 — intervention group
Group type: EXPERIMENTAL
Intervention: Richieri-Costa-Pereira syndrome group
Number of subjects: 9
Study 29863549 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 9
Study 27004659 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual feedback for a target hop height
Number of subjects: 27
Study 27004659 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile feedback for a target hop height
Number of subjects: 27
Study 27004659 — intervention group
Group type: COMPARATOR
Intervention: No feedback
Number of subjects: 27
Study 27004659 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual feedback
Number of subjects: 27
Study 25901838 — intervention group
Group type: EXPERIMENTAL
Intervention: 33-G needle
Number of subjects: 36
Study 25901838 — intervention group
Group type: COMPARATOR
Intervention: 30-G needle
Number of subjects: 36
Study 23934005 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive coping strategies
Number of subjects: 168
Study 23934005 — intervention group
Group type: EXPERIMENTAL
Intervention: Maladaptive coping strategies
Number of subjects: 168
Study 23934005 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive affect and social support
Number of subjects: 168
Study 23934005 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative affect
Number of subjects: 168
Study 20599300 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy providing liquids (EPL) given to infants
Number of subjects: 1368
Study 20599300 — intervention group
Group type: COMPARATOR
Intervention: Formula-fed infants (FF)
Number of subjects: 1368
Study 19391325 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal stabilisation exercises
Number of subjects: 9
Study 16875654 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics (metronidazole 250 mg and erythromycin 250 mg at 20 to 24 weeks of gestation 3 times daily for 7 days and metronidazole 250 mg and ampicillin 500 mg every 4 hours during labor)
Number of subjects: 0
Study 16875654 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12548304 — intervention group
Group type: EXPERIMENTAL
Intervention: Soya scones (120 mg/day of isoflavones)
Number of subjects: 20
Study 12548304 — intervention group
Group type: COMPARATOR
Intervention: Wheat scones (control)
Number of subjects: 20
Study 10861339 — intervention group
Group type: EXPERIMENTAL
Intervention: Tribulus terrestris (3.21 mg per kg body weight daily)
Number of subjects: 15
Study 10861339 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 9166318 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 400 micrograms orally (group 1)
Number of subjects: 20
Study 9166318 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 800 micrograms vaginally (group 2)
Number of subjects: 20
Study 1590705 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin for 5 days
Number of subjects: 232
Study 1590705 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin for 3 days
Number of subjects: 232
Study 1590705 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 232
Study 1590705 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin for 5 days (shigellosis)
Number of subjects: 232
Study 1590705 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin for 3 days (all cases)
Number of subjects: 232
Study 1590705 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin for 3 days (enterotoxigenic E. coli)
Number of subjects: 232
Study 1590705 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin for 3 days (shigellosis)
Number of subjects: 232
Study 1590705 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin for 3 days (bacterial enteropathogen)
Number of subjects: 232
Study 1590705 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin for 3 days (numerous leukocytes in stool)
Number of subjects: 232
Study 1590705 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 232
Study 1590705 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 232
Study 3703176 — intervention group
Group type: EXPERIMENTAL
Intervention: PK 8165 (50, 100, 150 mg)
Number of subjects: 8
Study 3703176 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 3703176 — intervention group
Group type: COMPARATOR
Intervention: Control session (no treatment)
Number of subjects: 8
Study 29926988 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine 8 mg/day
Number of subjects: 60
Study 29926988 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine 16 mg/day
Number of subjects: 60
Study 29926988 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 28069279 — intervention group
Group type: EXPERIMENTAL
Intervention: Masitinib (6 mg/kg per day over 24 weeks)
Number of subjects: 135
Study 28069279 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study 26308758 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadruple therapy (20 mg of omeprazole, 1g of amoxicillin, 500 mg of metronidazole, and 400 mg of bismuth compound for 7 days)
Number of subjects: 210
Study 26308758 — intervention group
Group type: EXPERIMENTAL
Intervention: Pylorex Plus (500 mg for 15 days)
Number of subjects: 210
Study 26308758 — intervention group
Group type: EXPERIMENTAL
Intervention: Pylorex Plus
Number of subjects: 210
Study 26308758 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadruple therapy
Number of subjects: 210
Study 23147078 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized birth weight percentiles (LGAcust)
Number of subjects: 491
Study 23147078 — intervention group
Group type: COMPARATOR
Intervention: Population birth weight percentiles (LGApop)
Number of subjects: 491
Study 23147078 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized and population norms
Number of subjects: 491
Study 20577116 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical diclofenac sodium 0.1%
Number of subjects: 22
Study 20577116 — intervention group
Group type: COMPARATOR
Intervention: Hydroxypropyl methyl cellulose (control)
Number of subjects: 22
Study 18713259 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive antimicrobial photodynamic therapy (aPDT)
Number of subjects: 20
Study 18713259 — intervention group
Group type: COMPARATOR
Intervention: Control group (scaling and root planing only)
Number of subjects: 20
Study 18713259 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (with and without adjunctive aPDT)
Number of subjects: 20
Study 16365181 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy in CALGB studies for extensive-stage small-cell lung cancer
Number of subjects: 995
Study 12941995 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose combination therapy regimen 1
Number of subjects: 0
Study 12941995 — intervention group
Group type: COMPARATOR
Intervention: Fixed-dose combination therapy regimen 2
Number of subjects: 0
Study 11055467 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 6614
Study 11055467 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium antagonists
Number of subjects: 6614
Study 11055467 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (beta-blockers and diuretics)
Number of subjects: 6614
Study 9484109 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactitol (4-O (beta-galactosyl)-D-glucitol)
Number of subjects: 12
Study 9484109 — intervention group
Group type: COMPARATOR
Intervention: Sucrose (control)
Number of subjects: 12
Study 7831429 — intervention group
Group type: EXPERIMENTAL
Intervention: Yohimbine (0.4 mg/kg)
Number of subjects: 7
Study 7831429 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 7
Study 3523740 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole, 40 mg/day
Number of subjects: 18
Study 31630249 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-esophageal injection of 10 mL of thickened water at 10 mL/s
Number of subjects: 10
Study 31630249 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-esophageal injection of 3 mL of thickened water at 10 mL/s
Number of subjects: 10
Study 31630249 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-esophageal injection in the upper region
Number of subjects: 10
Study 31630249 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary swallowing in the upper esophageal region
Number of subjects: 10
Study 31201136 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularisation (bypass or angioplasty)
Number of subjects: 452
Study 27988356 — intervention group
Group type: EXPERIMENTAL
Intervention: Black race
Number of subjects: 2972
Study 27988356 — intervention group
Group type: COMPARATOR
Intervention: White race
Number of subjects: 2972
Study 26651478 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended cognitive behavioural therapy
Number of subjects: 156
Study 26651478 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face cognitive behavioural therapy
Number of subjects: 156
Study 23458040 — intervention group
Group type: EXPERIMENTAL
Intervention: Identification of recurrent laryngeal nerve during surgery (Group A)
Number of subjects: 100
Study 23458040 — intervention group
Group type: COMPARATOR
Intervention: No identification of recurrent laryngeal nerve during surgery (Group B)
Number of subjects: 100
Study 20981504 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospective ECG gating
Number of subjects: 60
Study 20981504 — intervention group
Group type: COMPARATOR
Intervention: Retrospective ECG gating
Number of subjects: 60
Study 20008244 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic donor transplantation
Number of subjects: 0
Study 20008244 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive pediatric protocols
Number of subjects: 0
Study 20008244 — intervention group
Group type: COMPARATOR
Intervention: Matched unrelated donors
Number of subjects: 0
Study 20008244 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-intensity conditioning
Number of subjects: 0
Study 20008244 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic transplantation
Number of subjects: 0
Study 20008244 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal residual disease studies
Number of subjects: 0
Study 17926617 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) plus behavior therapy
Number of subjects: 60
Study 17926617 — intervention group
Group type: COMPARATOR
Intervention: Behavior therapy
Number of subjects: 60
Study 14693413 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose (titrated to a maximum of 100mg three times daily)
Number of subjects: 96
Study 14693413 — intervention group
Group type: COMPARATOR
Intervention: Tolbutamide (titrated to a maximum of 2000 mg in three doses)
Number of subjects: 96
Study 14693413 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 96